Timothy Morris
2021
In 2021, Timothy Morris earned a total compensation of $777.3K as Chief Operating and Financial Officer at KaloBios Pharmaceuticals, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,983 |
|---|---|
| Option Awards | $152,487 |
| Salary | $475,000 |
| Other | $5,800 |
| Total | $777,270 |
Morris received $475K in salary, accounting for 61% of the total pay in 2021.
Morris also received $144K in non-equity incentive plan, $152.5K in option awards and $5.8K in other compensation.
Rankings
In 2021, Timothy Morris' compensation ranked 9,574th out of 12,415 executives tracked by ExecPay. In other words, Morris earned more than 22.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,574 out of 12,415 | 23rd |
Division Manufacturing | 4,247 out of 5,505 | 23rd |
Major group Chemicals And Allied Products | 1,882 out of 2,375 | 21st |
Industry group Drugs | 1,670 out of 2,096 | 20th |
Industry Pharmaceutical Preparations | 1,244 out of 1,546 | 20th |
Source: SEC filing on April 12, 2022.
Morris' colleagues
We found two more compensation records of executives who worked with Timothy Morris at KaloBios Pharmaceuticals in 2021.